Seoul National University Hospital: Cholangiocarcinoma trials

The registry lists 12 Cholangiocarcinoma studies with Seoul National University Hospital as lead sponsor. 3 are open to participants now and 1 have results posted.

Phase 2 3Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Scout Dose of Resin MicrospheresRecruitingNCT07476651Not applicable
• Streamlining Radioembolization for CCC and Metastatic Liver CancerRecruitingNCT07043387
• AZD6738 Plus Durvalumab in Biliary Tract CancerRecruitingNCT04298008Phase 2
• Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary CancersCompletedNCT01134276Not applicableResults posted
• Streamlining Radioembolization for Intrahepatic CholangiocarcinomaTerminatedNCT07043348
• Role of Adjuvant Chemotherapy in Distal CholangiocarcinomaCompletedNCT06671431
• Outcomes and Prognostic Factors in HepatopancreatoduodenectomyCompletedNCT06631352
• Effect of PVE on Surgical Outcomes and Long-term Survival in Perihilar CholangiocarcinomaCompletedNCT06222619
• Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary CancerStatus unknownNCT05596370
• DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract CancerActive, not recruitingNCT04298021Phase 2
• Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver MalignanciesCompletedNCT02683538Phase 2
• Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas CancerStatus unknownNCT01111591Phase 4